LivaNova PLC (NAS:LIVN)
$ 61.96 -0.92 (-1.46%) Market Cap: 3.36 Bil Enterprise Value: 3.72 Bil PE Ratio: 0 PB Ratio: 2.75 GF Score: 75/100

LivaNova PLC at UBS Global Healthcare Conference Transcript

May 22, 2019 / 02:00PM GMT
Release Date Price: $72.11 (-0.59%)
Unidentified Analyst

Thanks, everybody, for joining us for this session. We're going to be joined here by management from LivaNova, including Damien McDonald, the CEO. Damien is previously the COO of LivaNova, and prior to that he was Group Executive and CVP at Danaher where he led a $1.5 billion group of dental consumables companies. And then all the way over here on stage left is Thad Huston, the CFO of LivaNova, who joined after more than 25 years of experience at J&J, where he most recently served as the Group's CFO of the medical devices business.

So to start off, I'd like to just give you the floor and have you talk a little bit about the current state of affairs at LivaNova. Maybe you can talk about the company's strategy, where you're going, touch on the core businesses, some of the pipeline opportunities and we'll get more in depth as the conversation goes along. All right?

Damien?

Damien McDonald
LivaNova PLC - CEO & Director

Do you want to do it for me or we just going to sit down?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot